COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Current Fellows

Fourth Year Fellows (PSTP Program)

Shiruyeh Schokrpur, MD, PhD

PSTP Program

Hometown: Fresno, CA

Medical School: University of California, Los Angeles David Geffen School of Medicine

IM Residency: University of California, San Diego

PhD Program: University of California, Los Angeles David Geffen School of Medicine

What is your favorite part of UCSD fellowship? The variety of patient experiences among clinical sites, including seeing patients on clinical trial at Moores Cancer Center.

Research and Career Interests: I am very interested in a career in translational medicine and this guides my current research interests. These focus on developing new ways to enhance immunotherapy responses. I am also interested in developing new predictive markers to guide clinical use of immunotherapy. I am currently mentored by Dr. Silvio Gutkind in the Department of Pharmacology and Dr. Sandip Patel in the department of Hematology and Oncology. 


  • Schokrpur S, Patel SP. Genomic Testing in Non-Small Cell Lung Cancer: From the Bench to the Clinic. ASCO Daily News. July 7, 2022.
  • Saddawi-Konefka RS, O’Farrell A, Faraji F, Clubb L, Allevato M,…Schokrpur S, et al. Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC. Nature Communications. Accepted July 7, 2022.
  • Schokrpur S, Patel S. Molecularly directed therapy of advanced/metastatic non-small cell lung cancer. IJCCD. Published online January 13, 2022:31316. doi:10.53876/001c.31316
  • Schokrpur S, Hilburn V, Giustini N, Bazhenova L. An overview of alectinib hydrochloride as a treatment option for ALK positive non-small cell lung cancer. Expert Opin Pharmacother. 2021;22(14):1815-1824. doi:10.1080/14656566.2021.1948014
  • Kelly K, Chen S, Eldredge JB, Benjamin DJ, Patel SP, Mulroy MC, Tabbara N, Sharp J, Chan J, Cummings AL, Daly ME, Goldman JW, Gubens MA, Harris JP, Onaitis MW, Schokrpur S, and Zhu VW. Role of Chemotherapy Plus Immune Checkpoint Inhibition in Oncogenic Driven Lung Cancer:A University of California Lung Cancer Consortium Retrospective Study. 2021 ASCO Annual Meeting; 2021 June 4-8; Chicago, IL.
  • Hu J*, Schokrpur S*, et al. A Non-integrating lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model. Molecular Therapy – Methods & Clinical Development. 2018 Jun 15; 9:203-10. 
  • Schokrpur S, et al. Syncope with a Sinister Source: An Extremely Rare Presentation of a Mediastinal Liposarcoma. Accepted for poster presentation at the American Thoracic Society International Conference 2018; 2018 May 18-21; San Diego, CA.
Hobbies: Exploring restaurants and breweries, hiking and beaches.

Third Year Fellows (Class of 2023)

Jeremy Chang, MD (Chief Fellow)

Hometown: Moraga, CA

Medical School: University of California, San Diego School of Medicine

IM Residency: Los Angeles County & University of Southern California, Los Angeles CA

What is your favorite part of UCSD fellowship? The supportive program leadership and all of my wonderful co-fellows! Also being able to live in beautiful San Diego.

Research and Career Interests: I am primarily interested in clinical and translational research for solid tumors including hepatocellular carcinoma and other GI malignancies.


  • Ronot, M., Chernyak, V., Burgyne, A., Chang, J., Jiang,H., Bashir, M., Fowler, K. Imaging to predict prognosis in hepatocellular carcinoma: current and future perspectives. In submission.
  • Franses, J., Lim, M., Burgoyne, A., MOdy, K., Lennerz, J., Chang, J., Imperial, R., Dybel, S., Dinh, T., Masannat, J., Weipert, C., Hsiehchen, D. Profile and predictors of blood tumor mutational burden in advanced hepatocellular carcinoma. In submission.
  • Chang, J.S., Fowler, K., Ting, S., Tamayo, P., Burgoyne, A. Molecular Alterations as Predictors of Response to Immunotherapy in Hepatocellular Carcinoma. European Society for Medical Oncology Congress 2022 in Paris, France. Planned September 2022.
  • Chang, J.S., Ryan, J., Ahmera, V., Fowler, K., Ting, S., Tamayo, P. Burgoyne, A. Responses to Immunotherpy in Hepatocellular Carcinoma Patiensts with Nonalcoholic Fatty Liver Disease Cirrhosis. 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco, CA. January 21, 2022.
  • Chang, J.S., Douer, D., Aldoss, I., Vahdani, G., Jeong, A.R., Ghaznavi, Z., Zhang, S.S., Yaghmour, G., Lee, K.J., Weissman, A., & Akhtari, M. Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia. Cancer Medicine. 2019, Jun; 8(6): 2832-2839.
  • Chang, J.S., Hsiao, M., Blodget, E., & Akhtari, M. Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation. Journal of Blood Medicine. 2019, May; 10(1): 135-143.
  • Chang, J.S., Tran, J., Kamel, D., & Basu, A. Nivolumab-induced hypophysitis leading to hypopituitarism and secondary empty sella syndrome in a patient with non-small cell lung cancer. BMJ Case Reports. 2019, Mar; 12(3): e228135.
  • Chang, J.S., Kwan, B., Panjwani, N., Villanueva, N., Diamond, S., Wong-Sefidan, I., & Muchmore, E. Prostate adenocarcinoma metastases to the testis and brain: case report and review of the literature. Oxford Medical Case Reports. 2017, Aug; 2017(8): 142–144.
  • Castro, J.E., Choi, M.Y., Carvajal, T., Almahasnah, E., Chang, J.S., James, D.F., & Kipps, T.J. Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia. Blood Cancer Journal. 2014, Nov; 4(11): 258.

Hobbies Traveling, cooking steak, swimming, NBA basketball

Michael Dennis, MD

Hometown: Danville, NH

Medical school: Virginia Commonwealth University School of Medicine

IM Residency: Boston University/Boston Medical Center, Boston MA

What is your favorite part of UCSD fellowship? My favorite part of the fellowship is the people I interact with on a regular basis (faculty, fellows, nursing, support staff, and patients). It also helps that we are located in a beautiful warm climate.

Research and Career Interests: I am interested broadly in cancer immunotherapy and early phase clinical trials. A more specific interest is improving the efficacy and safety of different types of immunotherpies using patient specific markers and/or clinical charecteristics. I want to work at an academic center after fellowship, specializing in thoracic oncology.


  • Edwards C, Sheikh A, Dennis MJ, Hunter A, Catudal E, Sarosiek S. "The Impact of Substance Use on Health Care Utilization, Treatment, and Outcomes in Patients with non-small cell lung cancer." Manuscript subitted to Journal of Thoracic Disease.
  • Bylsma S, Yun K, Patel S, Dennis MJ. "Immune Checkpoint Inhibitor Rechallenge after Prior Immune Toxicity." Manuscript submitted to Current Treatment Options in Oncology.
  • Dennis MJ, Sacco AG, Qi Y, Bykowski J, Pittman E, Chen R, Messer K, Cohen EEW, Gold KA. "A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma." Manuscript submitted to European Journal of Cancer.
  • Hildebrand L, Pierce C, Dennis M, Paracha M, Maoz A. "Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer." Cancers (Jan., 2021).
  • Gupta V, Dennis M, Ko N. "Identifying Actionable Causes of Potentially Avoidable Readmissions to an Oncology Service at a Safety Net Hospital." JCO Oncology Practice (March 2021)
  • Dennis M, Maoz A, Cirstea D, Lerner A, Patel A, Sarosiek S. "Treatment Disparities in Minority Groups with Multiple Myeloma at a Large Safety-Net Hospital." Leukemia and Lymphoma (May, 2020).
  • White P, Dennis M, Jone E, Weinberg J, Sarosiek S. "Risk Factors for the Development of Hypocalcemia in Cancer Patients Treated with Bone Modifying Agents." JNCCN (Apr., 2020). 
  • Dcona MM, Damle PK, Zarate-Perez F, Morris BL, Nawaz Z, Dennis M, Deng X, Korwar S, Singh S, Ellis KC, Royer WE, Bandyopadhyay D, Escalante C, Grossman SR. "Active-site tryptophan, the target of anti-neoplastic CtBP inhibitors, mediates inhibitor disruption of CtBP oligomerization and transcription coregulatory activities." Molecular Pharmacology (2019). 
  • Dennis M, Maoz A, Hughes D, Sanchorawala V, Sloan JM, Sarosiek S. "Bortezomib ocular toxicities: Outcomes with ketotifen." Am J Hematol (2019). DOI: 10.1002/ajh.25382.
  • Maoz A, Dennis M, Greenson J. "The Crohn's-like lymphoid reaction to colorectal cancer - tertiary lymphoid structures with immunologic and potentially therapeutic relevance in colorectal cancer." Frontiers in Immunology (2019). 
  • Qiao S, Dennis M, Song X, Vadysirisack DD, Salunke D, Nash Z, Yang Z, Liesa M, Yoshioka J, Matsuzawa S, Shirihai OS, Lee RS, Reed JC, Ellisen LW. "A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity." Nature Communications (2015). 

Hobbies I am married and have a daughter. We love spending time at the beach, at the zoo, and exploring local parks. I also like fishing, boating, and sports. I am a huge fan NFL football.

Nisha Hariharan, MD

Hometown: Fremont, CA

Medical School: Pennsylvania State University College of Medicine

IM Residency: University of California, Davis, Sacramento CA

What is your favorite part of UCSD fellowship? Great teaching from faculty, a perfect balance of strong clinical training and academics, and getting to live in sunny San Diego!

Research and Career Interests: My research interest is in malignant hematology, and my mentor is Dr. Goodman. 


  • Hariharan N, et al. Bleeding in patients with sickle cell disease: a population-based study. Blood Adv. 2020. 10;4(5): 793-802.
  • Hariharan N, et al. Examination of the cumulative incidence of all bleeding in patients with sickle cell disease: a population-based study. Oral Presentation at ASH Annual Meeting and Exposition, San Diego. December 1, 2018.
  • Pham B, Hoeg R, Hariharan N, et al. Treatment with FLAG followed by second allogeneic stem cell transplant for relapsed acute myeloid leukemia and myelodysplastic syndrome. ASCO meeting 2019.
  • Hariharan N, Chen BY, Olympia R. Implementation of an MRI program for the evaluation of pediatric right lower quadrant abdominal pain: effect on emergency department length of stay in adolescent females. Oral Presentation at American College of Emergency Physicians Research Forum, Las Vegas, October 2016.
  • Xu XM, ..., Hariharan N, et al. Chaperonins facilitate KNOTTED1 cell-to-cell trafficking and stem cell function. Science. 2011. 333(6046): 1141-44.

HobbiesSpending time outdoors (hiking, running, visiting San Diego's beautiful beaches), playing piano 

Anupama Kumar, MD

Hometown: Palo Alto, CA

Medical School: Tufts University School of Medicine

IM Residency: Tufts Medical Center, Boston MA

What is your favorite part of UCSD fellowship? The excellent teaching from the faculty, the encouragement from program leadership, and the supportive environment created by my co-fellows.

Research and Career Interests: I am primarily interested in malignant hematology. 


  • Kumar, A.D.Inker, L.A., Drew, D.A., Comenzo, R.L., Varga, C. (2019). Monoclonal gammopathies and their significance: A retrospective analysis of monoclonal gammopathy and renal disease. Presented as oral presentation at Internal Kidney and Monoclonal Gammopathy (IKMG) Research Group Meeting; Montreal, Canada. 
  • Godara, A., Kumar, A., Miller, K.B., Saif, M.W. (2021). Myelodysplastic Syndrome in Patients with Gastro-Pancreatic Malignancies: A Case Series and Review of Literature. Cancer Med J. 4 (2): 52-59. 

Hobbies: Hiking, salsa dancing, exploring new areas in San Diego

Elizabeth Pan, MD

Hometown: Miami, FL

Medical School: Keck School of Medicine of the University of Southern California

IM Residency: University of Southern California, Los Angeles CA

What is your favorite part of UCSD fellowship? The people, especially my co-fellows. 

Research and Career Interests: I am interested in solid tumors and specifically GU oncology. 


  • Pan E, Bogumil D, Cortessis V, Yu S, Nieva J. "A systemic review of the efficacy of preclinical models of lung cancer drugs." April 23, 2020.

Hobbies: Exploring new dessert places, perfecting matcha lattes, going to concerts/music festivals.

Karen Yun, MD

Hometown: Irvine, CA

Medical School: Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo

IM Residency: University of California, San Diego

What is your favorite part of UCSD fellowship? The camaraderie among fellows and faculty. 

Research and Career Interests: I am interested in head and neck thoracic oncology. My research mentor is Dr. Bazhenova. 


  • Yun K, Bazhenova LA. Update on Lerlatinib: Role in Reducing the Risk of Disease Progression in ALK-Positive NSCLC. Cancer Manag Res. 2022;14:843-850.
  • Yun K, Bazhenova L. "Clinical Outcomes of Patients with Advanced EGFR-Mutated NSCLC who Received Initial Treatment with Chemotherapy Followed by EGFR TKI." IASLC 2022 Targeted Therapies of Lung Cancer Meeting. February 24-26, 2022.
  • Yun K, Bazhenova L. "Clinical Outcomes of Patients with Advanced EGFR-Mutated NSCLC who Received Initial Treatment with Chemotherapy Followed by EGFR TKI." EGFR Resisters Research Meeting. November 14-15, 2021.
  • Yun K, Daniels G, Gold K, Mccowen K, Patel SP. Rapid onset type 1 diabetes with anti-PD-1 directed therapy. Oncotarget. 2020 Jul 14;11(28):2740-2746.

Hobbies: Running, biking, hiking. 

Second Year Fellows (Class of 2024)

Hemali Batra-Sharma, MD

Hometown: Des Moines, IA

Medical School: University of Iowa Carver College of Medicine

IM Residency: University of California, San Diego

What is your favorite part of UCSD fellowship?  My co-fellows, our faculty mentors' teaching and support, and life in beautiful San Diego

Research and Career Interests:  Academic breast medical oncology and global health


  • Kiser ET, Wacker MA, Gaur Dixit U, Batra-Sharma H, Chen Y, Wilson ME. The Inflammatory Effects of Dietary Lipids Regulate Growth of Parasites during Visceral Leishmaniasis. mSphere. 2021 Aug 25;6(4):e0042321. PMID: 34259561.
  • Batra-Sharma H, Sell R, Stefanko DP, Mahooti S. Hepatoid Adenocarcinoma of the Lung. American THoracic Society 2020 Annual Conference.
  • Kiser ET, Lima ID, Gaur Dixit U, Turcott EA, Lockard RD, Batra-Sharma H, Nascimento EL, Jeronimo SMB, Wilson ME. Epidemiological and Experimental Evidence for Sex-Dependent Differences in the Outcome of Leishmania Infantum Infection. American Journal of Tropical Medicine and Hygiene. 2018 Jan; 98(1): 142-145. PMID: 29165220.

Hobbies: Travel, hiking, Pilates, cooking with friends and family

Justin Chen, MD

Hometown: Salt Lake City, UT

Medical School: Baylor College of Medicine

IM Residency: University of California, San Diego

What is your favorite part of UCSD fellowship?  The people! I chose to stay at UCSD for fellowship becasue I knew that I would thrive here. The faculty are extremely supportive, helpful, and egaged in fellow education and my co-fellows are extremely down-to-earth and friendly

Research and Career Interests:  Currently pursuing research into indolent lymphomas and CLL. Considering a career in academic hematology of in cimmunity practice


  • Chen CJ, Kim LT, Weaver A, Cruz D, Patel SP. Characterizing severe acute kidney injury in patients treated with immune checkpoint inhibitors. Poster presented at Society for Immunotherapy of Cancer Annual Meeting. 2020 Nov 10-15

Hobbies: Running, hiking, exploring San Diego's breweries, and searching for the best California burrito in San Diego

Renee Cheng, MD

Hometown: Naperville, IL

Medical School: University of Illinois at Chicago

IM Residency: University of Illinois, Chicago, IL

What is your favorite part of UCSD fellowship?  The faculty members are all very supportive and love to teach. My co-fellows create a great community as well. Plus, the weather is beautiful here.

Research and Career Interests:  Malignant Hematology


  • Cheng R, Singh A, Nasa P, Han J, Zhang X, Alfaro D. Kavoliunaite L, Nwachukwu C, Woodward K, Molokie R, Gordeuk V, & Gowhari M. (December, 2020). Outcomes in Vaso-Occlusive Crisis Treatment in the Emergency Department vs. Acute Care Observation Center. Poster presented at: American Society of Hematology (ASH) Annual Meeting 2020; San Diego, CA USA.
  • Cheng, R., Srisuwananukorn, A., Han, J., Gowhari, M., Njoku, F., Hussain, F.A., Molokie, R., Gordeuk, V.R., & Saraf, S.L.. (December, 2020). Lower Apache II Score and Exchange Transfusions Predict Better Outcomes in the Intensive Care Unit for Patients with Sickle Cell Disease. Poster presented at: American Society of Hematology (ASH) Annual Meeting 2020; San Diego, CA, USA.
  • Cheng, R., Patel R., Kang, S., Tian F., Zhang X., Han J., Patel J., Zilberstein N., Gordeuk V., & Gowhari M.. (December, 2019). Imple mentation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit. Poster presented at: American Society of Hematology (ASH) Annual Meeting 2019; Orlando, FL, USA.
  • Kwan J.M., Cheng R.G., & Feldman L.E.. Hepatotoxicity and Recurrent NSTEMI While on Pembrolizumab for Metastatic Giant Cell Bone Tumor. The American Journal of the Medical Sciences. 2019, Apr; 357(4): 343-347. Cited in PubMed; PMID: 30638772.
  • Price T.T., Burness M.L., Sivan A, Warner M.J., Cheng R., Lee C.H., Olivere L., Comatas K., Magnani J., Kim Lyerly H., Cheng Q., McCall C.M., Sipkins D.A.. Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone. Science Translational Medicine. 2016, May; 8(340): 340-73. Cited in PubMed; PMID: 27225183.
  • Price T., Burness M., Sivan A., Cheng R., Mangnani J.L., & Sipkins D.A.. (April, 2014). Breast Cancer Cells Metastasize to Bone through E-Selectin Positive Vascular Gateways. Poster presented at: American Association of Cancer Research (AACR) Annual Meeting 2014; San Diego, CA, USA.
  • Marcus E., Holloway N., Galligan C., Cheng R., McDunn M., Robinson P., & DeVine K.. (June, 2011). Oncology Appointment Compliance in Navigated and Non-Navigated Patients Receiving Radiation Therapy in an Urban Public Hospital. Poster presented at: American Society of Clinical Oncology (ASCO) Annual Meeting 2011; Chicago, IL, USA.

HobbiesA new hobby I've picked up in San Diego is bird watching. Otherwise, I enjoy spending time with friends and family and exploring San Diego.

Sharon Choi, MD, PhD

Hometown: Orange County, CA

Medical School: University of Illinois College of Medicine, Chicago

IM Residency: University of California, San Diego

What is your favorite part of UCSD fellowship?  The people and supportive environment make our program stand out.. you also can’t beat San Diego.

Research and Career Interests:  Translational research in solid tumor oncology


  • Choi, S.H., Smith, S.A., & Morrissey, J.H. (2017). Polyphosphate accelerates factor V activation by factor XIa. Thrombosis and Haemostasis, 113(3), 599–604.
  • Choi, S.H., Smith, S.A., & Morrissey, J.H. Platelet Polyphosphate Enhances Activation of Factor XI by Thrombin. American Society of Hematology Annual Meeting. Orlando, FL. December, 2015.
  • Puy, C., Tucker, E.I., Wong, Z.C., Gailani, D., Smith, S.A., Choi, S.H., McCarty, O.J.T. (2015). Factor XII promotes blood coagulation independent of factor XI in the presence of long chain polyphosphate. Journal of Thrombosis and Haemostasis: JTH11(7), 1341–1352.
  • Choi, S.H., Smith, S.A., Collins, J.N., Travers, R.J., Cooley, B.C., & Morrissey, J.H. (2014). Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation. Blood, 120(26), 5103-5110.
  • Choi, S.H., Smith, S.A. & Morrissey, J.H. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. International Society on Thrombosis & Hemostasis Biennial Congress. Kyoto, Japan. July, 2014.
  • Choi, S.H., Smith, S.A., & Morrissey, J.H. (2013). Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood, 118(26), 6963-6970.
  • Morrissey, J.H., Choi, S.H., & Smith, S.A. (2014). Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood, 119(25), 5972-5979.
  • Choi, S.H., Collins, J.N.R., Smith, S.A., Davis-Harrison, R.L., Rienstra, C.M., and Morrissey, J.H.  (2013). Phosphoramidate end labeling of inorganic polyphosphates: Facile manipulation of polyphosphate for investigating and modulating its biological activities.  Biochemistry, 49:  9935-41.
  • Choi, S.H., Davis-Harrison, R.L., Smith, S.A., Collins, J.N.R., Rienstra, C.M., and Morrissey, J.H.  Covalent End-Labeling of Polyphosphate Facilitates Studies of Its Procoagulant Activities and Development of Enhanced Agents to Treat Bleeding. American Society of Hematology.  Atlanta, GA.  December 2012.
  • Choi, S.H. and Morrissey, J.H. Polyphosphate Accelerates Factor V Activation by Factor XIa. Gordon Research Conference – Hemostasis. Waterville Valley, NH. July 2012.
  • Smith, S.A., Choi, S.H., Davis-Harrison, R., Huyck, J., Boettcher, J., Rienstra, C.M., & Morrissey, J.H. (2012). Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood, 116(20), 4353-4359.
  • Helsten, T.L., Bunch, T.A., Kato, H., Yamanouchi, J., Choi, S.H., Jannuzi, A.L., Feral, C.C., Ginsberg, M.H., Brower, D.L., Shattil, S.J.  (2010).  Differences in regulation of Drosophila and vertebrate integrin affinity by talin.  Molecular Biology of the Cell, 8:  3589-98.

Hobbies: Cooking, trying out new food, Cardinals baseball, traveling (when time/money permits)

Peter Moussa, MD

Hometown: Cairo, Egypt

Medical School: St. George's University School of Medicine, Grenada

IM Residency: Albert Einstein Medical Center

What is your favorite part of UCSD fellowship?  Definitely the people! My co-fellows and faculty make fellowship here a very special experience. We also get to see a wide range of cases in hematology/oncology, as well as patients on clinical trials, affording fellows a great balance of academic and clinical exposure.

Research and Career Interests:  Solid tumor oncology. I am currently doing research with my mentor Dr. Shumei Kato looking into alternate immune co-stimulatory pathways that may be targeted to augment immune-system anti-cancer activity.


  • Moussa P, Fodil N, Vidal S. Cmv5: A Genetic Modulator of CMV Resistance. Poster presented at 13th meeting of Natural immunity 2012; Pacific Grove, CA, USA.
  • Moussa P, Fodil N, Vidal S. Exome Capture and Next Generation Sequencing to Identify Cmv5. Poster presented at the Canadian Human and Statistical Genetics meeting 2012; Niagara Falls, Ontario, Canada.
  • Moussa P, Marton J, Vidal SM, Fodil-Cornu N. Genetic dissection of NK cell responses. Front Immunol. 2013 Jan 18;3:425.
  • Fodil N, Langlais D, Moussa P (co-second), Boivin GA, Di Pietrantonio T, Radovanovic I, Dumaine A, Blanchette M, Schurr E, Gros P, Vidal SM. Specific dysregulation of IFNγ production by natural killer cells confers susceptibility to viral infection. PLoS Pathog. 2014 Dec 4;10(12):e1004511.
  • Moussa P, Abrahamsen G, Fodil N, Goazpalakrishnan RP, Mancini M, Dissen E, Sæther PC, Wiltshire SA, Boivin GA, Caignard G, Spurkland A, Vidal SM. Reduced MCMV Δm157 viral clearance in the absence of TSAd. Sci Rep. 2015 Mar 18;5:9219.
  • Fox T, Azmaiparashvili Z, Moussa P, Monla-Hassan J. Hemihyperplasia and Deep Vein Thrombosis: Clues to a Rare Underlying Syndrome (Klippel-Trenaunay syndrome). Poster presented at ACP South Eastern Regional annual conference 2018; Philadelphia, PA, USA.
  • Jorge V, Tiu A, Moussa P, Gupta S, Djibo DA, Dourado C. Survival Disparities of Diffuse Large B-Cell Lymphoma in a Community-Based Inner-City Cancer Center. Poster presented in ASCO annual meeting 2019; Chicago, IL, USA.
  • Moussa P, Tiu A, Stemple J, Lo K, Dourado C. IRIS posing as HLH in an AIDS patient with diffuse Kaposi sarcoma. Poster presented at ACP South Eastern Regional annual conference 2019; Philadelphia, PA, USA.
  • Kim K, Jorge V, Tiu A, Moussa P, Gupta S, Djibo D, Dourado C. Early Mortality after Diagnosis of Diffuse Large B-Cell Lymphoma: A Retrospective, Single Urban-Community Hospital Study. ASH 2019 conference abstract; Blood 2019; 134 (Supplement_1): 5335.
  • Tiu A, Jorge V, Moussa P, Djibo DA, Gupta S, Alpdogan O, Dourado C. Survival Disparities of Diffuse Large B-Cell Lymphoma in a Community-Based Inner-City Cancer Center. Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):205-215.
  • Swaminathan N, Moussa P, Mody N, Lo KB, Patarroyo-Aponte G. COVID-19 in HIV-infected patients: A case series and literature review. J Med Virol. 2021 May;93(5):2557-2563.

HobbiesSpending time with family, traveling, videogames, and finding good restaurants in SD. I also like soccer and a Liverpool fan.

Poorva Vaidya, MD

Hometown: Irvine, CA

Medical School: Georgetown University School of Medicine

IM Residency: University of Southern California, Los Angeles, CA

What is your favorite part of UCSD fellowship?  My co-fellows, the enthusiasm of faculty mentors, and living in San Diego!

Research and Career Interests:  Solid Tumor Oncology


  • In, GK., Vaidya, P., Filkins, A., Hermel, DJ., King, KG., Ragab, O., et al. (2020). PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California. J Cancer Res Clin Oncol. doi: 10.1007/s00432-020-03458-6.
  • Hasnain, Z., Nilanon, T., Li M., Mejia, A., Kolatkar A., Nocera, L., Shahabi, C., Cozzens Philips, FA., Lee, J., Hanlon, SE., Vaidya, P., Ueno, NT., Yennu, S., Newton PK., Kuhn, P., Nieva, J. (2020). Quantified kinematics to evaluate patient chemotherapy risks in clinic. JCO Clinical Cancer Informatics, 4:583-601. doi: 10.1200/CCI..20.00010
  • Vaidya, P., Khedro, K., Yaghmour, B., Yaghmour, G.  (2019). Midostaurin related interstitial lung injury in FLT3+ acute myeloid leukemia post-allogeneic transplant. World Journal of Oncology, 10(6):237-239. doi:10.14740/wjon1232
  • Hagiya, A., Vaidya, P., Khedro, T., Yaghmour B., Siddiqi I., Yaghmour G. (2019). Bone Marrow Features in Patients with acute myeloid leukemia treated with novel targeted isocitrate dehydrogenase 1/2 inhibitors. World Journal of Oncology, 10(6):226-230. doi: 10.14740/wjon1231
  • Vaidya, P., Ragab, O., Mehta, A., Lin, S., In, GK. (2019). Concurrent radiation therapy with programmed cell death protein 1 (PD-1) inhibition leads to a complete response in advanced, cutaneous squamous cell carcinoma. JAAD Case Reports, 5(9): 763-766. doi: 10.1016/j.jdcr.2019.06.026
  • Montoya, D., Inkeles M., Liu, P., Realegeno, S., Teles, R., Vaidya, P…Modlin R.L. (2014). IL-32 is a molecular marker of a host defense network in human tuberculosis. Science Translational Medicine 6(250):250ra114.  doi: 10.1126/scitranslmed.3009546.

HobbiesBoard games, reading for book club, early morning hikes, finding San Diego's best coffee shops

First Year Fellows (Class of 2025)

Elizabeth Behrens Conner, MD

Hometown: Newburgh, IN

Medical School: University of Kentucky College of Medicine

IM Residency: Rush University, Chicago, IL

Kaitlyn Dykes, MD

Hometown: Byron, MN

Medical School: Sidney Kimmel Medical College, Thomas Jefferson University

IM Residency: MedStar Georgetown University, Washington, DC

Amanda Herrmann, MD

Hometown: Skillman, NJ

Medical School: Rutgers Robert Wood Johnson Medical School

IM Residency: University of Southern California, Los Angeles, CA

Tridu Huynh, MD

Hometown: San Diego, CA

Medical School: University of Vermont - College of Medicine

IM Residency: Scripps Green, La Jolla, CA

Katarina Vsiljevic, MD

Hometown: Belgrade, Serbia

Medical School: University of Maryland School of Medicine

IM Residency: University of California, San Diego, La Jolla CA 

Zoe Zhang, MD

Hometown: New York City, NY

Medical School: Duke University School of Medicine

IM Residency: Virginia Commonwealth University, Richmond, VA